Literature DB >> 31955339

Euploid rates among oocyte donors: is there an optimal age for donation?

Luis R Hoyos1, Connie Y Cheng2, Kathleen Brennan2, Gary Hubert2,3, Brandon Wang3, Richard P Buyalos2,3, Molly Quinn2, Mousa Shamonki2,3.   

Abstract

PURPOSE: To examine cycle blastocyst euploid rates among age subgroups of oocyte donors.
METHODS: Retrospective cohort analysis of ova donation in vitro fertilization cycles (OD-IVF) for which trophectoderm biopsy for preimplantation genetic testing for aneuploidy (PGT-A) by array comparative genomic hybridization (aCGH) or next generation gene sequencing (NGS) was employed between January 2015 and December 2018 in a single high-volume fertility center.
RESULTS: Compared to oocyte donors age 26-30, oocyte donors age ≤ 25 had similar cycle blastocyst euploid rates (80 [66.7, 87.5]%, vs. 75 [62.5, 87.5]%, median [IQR], p = 0.07), blastocyst formation rates (66.7 [50, 75]%, vs. 62.5 [52, 75]%, p = 0.55), and number of retrieved oocytes (29 [23, 37] vs. 27 [20, 35], p = 0.18). Age of oocyte donor from 18 to 34 was not correlated with cycle blastocyst euploid rate.
CONCLUSION: Oocyte donors age ≤ 25 had similar cycle blastocyst euploid rates, blastocyst formation rates, and number of retrieved oocytes compared to donors age 26-30. There was no correlation between cycle blastocyst euploid rates and age of the oocyte donor from 18 to 34 years. Given the lack of significant age-related change in cycle blastocyst euploid rates, our data support existing practices which do not favor a specific age subgroup of young oocyte donors.

Entities:  

Keywords:  Age; Aneuploidy; Egg donors; Euploid; IVF; Oocyte donors; Preimplantation genetic testing

Mesh:

Year:  2020        PMID: 31955339      PMCID: PMC7125283          DOI: 10.1007/s10815-020-01694-w

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  24 in total

1.  Validation of a next-generation sequencing-based protocol for 24-chromosome aneuploidy screening of blastocysts.

Authors:  Jin Huang; Liying Yan; Sijia Lu; Nan Zhao; X Sunney Xie; Jie Qiao
Journal:  Fertil Steril       Date:  2016-02-19       Impact factor: 7.329

Review 2.  Clinical application of embryo aneuploidy testing by next-generation sequencing.

Authors:  Carmen Rubio; Lorena Rodrigo; Carmen Garcia-Pascual; Vanessa Peinado; Inmaculada Campos-Galindo; Sandra Garcia-Herrero; Carlos Simón
Journal:  Biol Reprod       Date:  2019-12-24       Impact factor: 4.285

3.  Embryonic aneuploidy rates are equivalent in natural cycles and gonadotropin-stimulated cycles.

Authors:  Kathleen H Hong; Jason M Franasiak; Marie M Werner; George Patounakis; Caroline R Juneau; Eric J Forman; Richard T Scott
Journal:  Fertil Steril       Date:  2019-10       Impact factor: 7.329

Review 4.  The use of preimplantation genetic testing for aneuploidy (PGT-A): a committee opinion.

Authors: 
Journal:  Fertil Steril       Date:  2018-03       Impact factor: 7.329

5.  Euploidy rates in donor egg cycles significantly differ between fertility centers.

Authors:  S Munné; M Alikani; L Ribustello; P Colls; Pedro A Martínez-Ortiz; D H McCulloh
Journal:  Hum Reprod       Date:  2017-04-01       Impact factor: 6.918

6.  Are blastocyst aneuploidy rates different between fertile and infertile populations?

Authors:  Jonathan D Kort; Rajiv C McCoy; Zach Demko; Ruth B Lathi
Journal:  J Assist Reprod Genet       Date:  2017-10-23       Impact factor: 3.412

Review 7.  Female age-related fertility decline. Committee Opinion No. 589.

Authors: 
Journal:  Fertil Steril       Date:  2014-03       Impact factor: 7.329

8.  Effect of the male factor on the clinical outcome of intracytoplasmic sperm injection combined with preimplantation aneuploidy testing: observational longitudinal cohort study of 1,219 consecutive cycles.

Authors:  Rossella Mazzilli; Danilo Cimadomo; Alberto Vaiarelli; Antonio Capalbo; Lisa Dovere; Erminia Alviggi; Ludovica Dusi; Carlo Foresta; Francesco Lombardo; Andrea Lenzi; Herman Tournaye; Carlo Alviggi; Laura Rienzi; Filippo Maria Ubaldi
Journal:  Fertil Steril       Date:  2017-10-03       Impact factor: 7.329

9.  Trends and outcomes for donor oocyte cycles in the United States, 2000-2010.

Authors:  Jennifer F Kawwass; Michael Monsour; Sara Crawford; Dmitry M Kissin; Donna R Session; Aniket D Kulkarni; Denise J Jamieson
Journal:  JAMA       Date:  2013-12-11       Impact factor: 56.272

10.  Identification of mosaic and segmental aneuploidies by next-generation sequencing in preimplantation genetic screening can improve clinical outcomes compared to array-comparative genomic hybridization.

Authors:  Hsing-Hua Lai; Tzu-Hsuan Chuang; Lin-Kin Wong; Meng-Ju Lee; Chia-Lin Hsieh; Huai-Lin Wang; Shee-Uan Chen
Journal:  Mol Cytogenet       Date:  2017-04-26       Impact factor: 2.009

View more
  4 in total

1.  Preimplantation genetic testing for aneuploidies does not increase success rates in fresh oocyte donation cycles: a paired cohort study.

Authors:  Carolina Lumertz Martello; Marcos Iuri Roos Kulmann; Luiza Mezzomo Donatti; Adriana Bos-Mikich; Nilo Frantz
Journal:  J Assist Reprod Genet       Date:  2021-10-05       Impact factor: 3.412

Review 2.  Preimplantation Genetic Testing: Where We Are Today.

Authors:  Ermanno Greco; Katarzyna Litwicka; Maria Giulia Minasi; Elisabetta Cursio; Pier Francesco Greco; Paolo Barillari
Journal:  Int J Mol Sci       Date:  2020-06-19       Impact factor: 5.923

Review 3.  A Mini-Review Regarding the Clinical Outcomes of In Vitro Fertilization (IVF) Following Pre-Implantation Genetic Testing (PGT)-Next Generation Sequencing (NGS) Approach.

Authors:  Bogdan Doroftei; Ovidiu-Dumitru Ilie; Nicoleta Anton; Theodora Armeanu; Ciprian Ilea
Journal:  Diagnostics (Basel)       Date:  2022-08-07

4.  Cost-effectiveness of preimplantation genetic testing for aneuploidy for fresh donor oocyte cycles.

Authors:  Maria Facadio Antero; Bhuchitra Singh; Apoorva Pradhan; Megan Gornet; William G Kearns; Valerie Baker; Mindy S Christianson
Journal:  F S Rep       Date:  2020-12-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.